About: Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $8.36 (+1.58%)
Status: deslistada — removed_from_provider. Este ativo não é mais negociado; são exibidos dados históricos.
ARMP NYSE Armata Pharmaceuticals Inc
Armata Pharmaceuticals Inc share price
Atividade de preço de ARMP
Último preço
Variação (24h)
USD
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/D
Último negócio
ARMP price performance
quote.marketSignals